CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Georg Schett, Melanie Hagen et al.|Nature Medicine|2026Cited by 43
A landscape of genetic heterogeneity in germline predisposition to familial chronic lymphocytic leukemiaLuca Laurenti, Dimitar G. Efremov, Giulia Rapari et al.|Research Square|2025Cited by 0